context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. ... | text | 55 | percentItemType | text: <entity> 55 </entity> <entity type> percentItemType </entity type> <context> International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as politica... | us-gaap:ConcentrationRiskPercentage1 |
. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity’s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. S... | text | 61 | monetaryItemType | text: <entity> 61 </entity> <entity type> monetaryItemType </entity type> <context> . The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity’s own equity, and modifies how certain convertible instruments and contracts that may ... | us-gaap:RetainedEarningsAccumulatedDeficit |
. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity’s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. S... | text | 93 | monetaryItemType | text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> . The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity’s own equity, and modifies how certain convertible instruments and contracts that may ... | us-gaap:AdditionalPaidInCapital |
We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these... | text | 477 | monetaryItemType | text: <entity> 477 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month ... | us-gaap:DerivativeNotionalAmount |
We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these... | text | 926 | monetaryItemType | text: <entity> 926 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month ... | us-gaap:DerivativeNotionalAmount |
We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these... | text | 432 | monetaryItemType | text: <entity> 432 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month ... | us-gaap:LossContingencyAccrualAtCarryingValue |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 621 | monetaryItemType | text: <entity> 621 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash ... | us-gaap:DerivativeNotionalAmount |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 628 | monetaryItemType | text: <entity> 628 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash ... | us-gaap:DerivativeNotionalAmount |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash f... | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash f... | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash f... | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash f... | us-gaap:DerivativeAssets |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash fl... | us-gaap:DerivativeAssets |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash fl... | us-gaap:DerivativeLiabilities |
We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other c... | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash f... | us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths |
The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical an... | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest r... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. | text | 37 | monetaryItemType | text: <entity> 37 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 37 million, $ 36 million, and $ 53 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
On June 24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The GRAIL common stock distributed in the Spin-Off consisted of approximately 85.5 % of the outstand... | text | 14.5 | percentItemType | text: <entity> 14.5 </entity> <entity type> percentItemType </entity type> <context> On June 24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The GRAIL commo... | us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal |
As part of the Spin-Off, we contributed to GRAIL an amount, in cash, to cover 2.5 years of GRAIL’s operations (the Disposal Funding), which was determined to be $ 974 million, less the cash and cash equivalents held by GRAIL. | text | 974 | monetaryItemType | text: <entity> 974 </entity> <entity type> monetaryItemType </entity type> <context> As part of the Spin-Off, we contributed to GRAIL an amount, in cash, to cover 2.5 years of GRAIL’s operations (the Disposal Funding), which was determined to be $ 974 million, less the cash and cash equivalents held by GRAIL. </context... | us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal |
Includes IPR&D with a carrying value of $ 140 million after impairment. Refer to note | text | 140 | monetaryItemType | text: <entity> 140 </entity> <entity type> monetaryItemType </entity type> <context> Includes IPR&D with a carrying value of $ 140 million after impairment. Refer to note </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets |
Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. | text | 2288 | monetaryItemType | text: <entity> 2288 </entity> <entity type> monetaryItemType </entity type> <context> Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. | text | 2359 | monetaryItemType | text: <entity> 2359 </entity> <entity type> monetaryItemType </entity type> <context> Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. | text | 2290 | monetaryItemType | text: <entity> 2290 </entity> <entity type> monetaryItemType </entity type> <context> Americas revenue included United States revenue of $ 2,288 million, $ 2,359 million, and $ 2,290 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping sched... | text | 657 | monetaryItemType | text: <entity> 657 </entity> <entity type> monetaryItemType </entity type> <context> We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The... | us-gaap:RevenueRemainingPerformanceObligation |
We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping sched... | text | 78 | percentItemType | text: <entity> 78 </entity> <entity type> percentItemType </entity type> <context> We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The t... | us-gaap:RevenueRemainingPerformanceObligationPercentage |
We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping sched... | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The t... | us-gaap:RevenueRemainingPerformanceObligationPercentage |
Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December 29, 2024 and December 31, 2023, were $ 16 million and $ 18 million, respectively, all of which were short-term and recorded in prepaid expenses and other curre... | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December 29, 2024 and December 31, 2023, were $ 16 million and $ 18 million, respect... | us-gaap:ContractWithCustomerAssetNet |
Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December 29, 2024 and December 31, 2023, were $ 16 million and $ 18 million, respectively, all of which were short-term and recorded in prepaid expenses and other curre... | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December 29, 2024 and December 31, 2023, were $ 16 million and $ 18 million, respect... | us-gaap:ContractWithCustomerAssetNet |
Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subseq... | text | 93 | monetaryItemType | text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in ou... | us-gaap:ShortTermInvestments |
Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subseq... | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in our... | us-gaap:ShortTermInvestments |
Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subseq... | text | 14.5 | percentItemType | text: <entity> 14.5 </entity> <entity type> percentItemType </entity type> <context> Our short-term investments consist of marketable equity securities. As of December 29, 2024 and December 31, 2023, the fair value of our marketable equity securities totaled $ 93 million and $ 6 million, respectively. The increase in o... | us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal |
for details. We recorded an unrealized loss of $ 309 million in 2024, subsequent to the Spin-Off, based on the fair value of our investment in GRAIL as of December 29, 2024. | text | 309 | monetaryItemType | text: <entity> 309 </entity> <entity type> monetaryItemType </entity type> <context> for details. We recorded an unrealized loss of $ 309 million in 2024, subsequent to the Spin-Off, based on the fair value of our investment in GRAIL as of December 29, 2024. </context> | us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax |
As of December 29, 2024 and December 31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $ 26 million and $ 28 million, respectively. | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024 and December 31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $ 26 million and $ 28 million, respectively. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
As of December 29, 2024 and December 31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $ 26 million and $ 28 million, respectively. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024 and December 31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $ 26 million and $ 28 million, respectively. </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of December 29, 2024 and December 31, 2023, respectively. We recorded a net gain of $ 5 mill... | text | 201 | monetaryItemType | text: <entity> 201 </entity> <entity type> monetaryItemType </entity type> <context> We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of Dece... | us-gaap:EquityMethodInvestments |
We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of December 29, 2024 and December 31, 2023, respectively. We recorded a net gain of $ 5 mill... | text | 168 | monetaryItemType | text: <entity> 168 </entity> <entity type> monetaryItemType </entity type> <context> We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of Dece... | us-gaap:EquityMethodInvestments |
We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of December 29, 2024 and December 31, 2023, respectively. We recorded a net gain of $ 5 mill... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of Decemb... | us-gaap:UnrealizedGainLossOnInvestments |
We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of December 29, 2024 and December 31, 2023, respectively. We recorded a net gain of $ 5 mill... | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of Decem... | us-gaap:UnrealizedGainLossOnInvestments |
We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of December 29, 2024 and December 31, 2023, respectively. We recorded a net gain of $ 5 mill... | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $ 201 million and $ 168 million as of Decem... | us-gaap:UnrealizedGainLossOnInvestments |
Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. | text | 69 | monetaryItemType | text: <entity> 69 </entity> <entity type> monetaryItemType </entity type> <context> Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. | text | 113 | monetaryItemType | text: <entity> 113 </entity> <entity type> monetaryItemType </entity type> <context> Revenue recognized from transactions with our strategic investees was $ 20 million, $ 69 million, and $ 113 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
In conjunction with the deconsolidation of Helix Holdings I, LLC (Helix) in April 2019, we received a contingent value right with a 7-year term that entitled us to consideration dependent upon the outcome of Helix’s future financing and/or liquidity events. We elected the fair value option to measure the contingent val... | text | 83 | monetaryItemType | text: <entity> 83 </entity> <entity type> monetaryItemType </entity type> <context> In conjunction with the deconsolidation of Helix Holdings I, LLC (Helix) in April 2019, we received a contingent value right with a 7-year term that entitled us to consideration dependent upon the outcome of Helix’s future financing and... | us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements |
, this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2... | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> , this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues for t... | us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities |
, this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2... | text | 803000 | monetaryItemType | text: <entity> 803000 </entity> <entity type> monetaryItemType </entity type> <context> , this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues fo... | us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities |
, this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2... | text | 396000 | monetaryItemType | text: <entity> 396000 </entity> <entity type> monetaryItemType </entity type> <context> , this will reflect a 2.5 % payment right to the first $ 1 billion of revenue each year for 12 years. Revenue above $ 1 billion each year will be subject to a 9 % contingent payment right during this same period. Covered Revenues fo... | us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities |
The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued li... | text | 71 | monetaryItemType | text: <entity> 71 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was include... | us-gaap:BusinessCombinationContingentConsiderationLiability |
The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued li... | text | 387 | monetaryItemType | text: <entity> 387 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was includ... | us-gaap:BusinessCombinationContingentConsiderationLiability |
The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued li... | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was include... | us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent |
The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued li... | text | 385 | monetaryItemType | text: <entity> 385 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of our contingent consideration liability related to GRAIL was $ 71 million and $ 387 million as of December 29, 2024 and December 31, 2023, respectively, of which $ 70 million and $ 385 million, respectively, was includ... | us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent |
The balance as of January 1, 2023 includes accumulated impairment of $ 3,914 million related to our GRAIL reporting unit. | text | 3914 | monetaryItemType | text: <entity> 3914 </entity> <entity type> monetaryItemType </entity type> <context> The balance as of January 1, 2023 includes accumulated impairment of $ 3,914 million related to our GRAIL reporting unit. </context> | us-gaap:GoodwillImpairedAccumulatedImpairmentLoss |
Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for our two reporting units: Core Illumina and GRAIL. We performed a quantitative test ... | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for... | us-gaap:NumberOfReportingUnits |
Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for our two reporting units: Core Illumina and GRAIL. We performed a quantitative test ... | text | 1466 | monetaryItemType | text: <entity> 1466 </entity> <entity type> monetaryItemType </entity type> <context> Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test f... | us-gaap:GoodwillImpairmentLoss |
To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers’ enterprise value estimates included estimated revenues for a two... | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the... | us-gaap:Goodwill |
To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers’ enterprise value estimates included estimated revenues for a two... | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the i... | us-gaap:Goodwill |
To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers’ enterprise value estimates included estimated revenues for a two... | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the i... | us-gaap:Goodwill |
To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers’ enterprise value estimates included estimated revenues for a two... | text | 974 | monetaryItemType | text: <entity> 974 </entity> <entity type> monetaryItemType </entity type> <context> To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the... | us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal |
We evaluated GRAIL’s IPR&D intangible asset for potential impairment, in May 2024, as part of our annual test. We also concluded that the when-issued trading activity for GRAIL’s common stock, in June 2024, represented a triggering event that required an additional impairment test be performed. The carrying value of th... | text | 420 | monetaryItemType | text: <entity> 420 </entity> <entity type> monetaryItemType </entity type> <context> We evaluated GRAIL’s IPR&D intangible asset for potential impairment, in May 2024, as part of our annual test. We also concluded that the when-issued trading activity for GRAIL’s common stock, in June 2024, represented a triggering eve... | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
In Q3 2023, we concluded that the sustained decrease in the Company’s stock price and overall market capitalization during the quarter was a triggering event indicating the fair values of our reporting units might be less than their carrying amounts and that an interim impairment test was required. Based on our analysi... | text | 712 | monetaryItemType | text: <entity> 712 </entity> <entity type> monetaryItemType </entity type> <context> In Q3 2023, we concluded that the sustained decrease in the Company’s stock price and overall market capitalization during the quarter was a triggering event indicating the fair values of our reporting units might be less than their ca... | us-gaap:GoodwillImpairmentLoss |
In conjunction with our interim goodwill impairment test, we also evaluated GRAIL’s IPR&D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted... | text | 109 | monetaryItemType | text: <entity> 109 </entity> <entity type> monetaryItemType </entity type> <context> In conjunction with our interim goodwill impairment test, we also evaluated GRAIL’s IPR&D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&D intangible asset to its ... | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
In Q4 2023, we concluded, among other events, that our formal announcement to divest GRAIL represented a triggering event that required an additional interim impairment test be performed. As a result of our analysis, no impairment was recorded for Core Illumina or GRAIL. The fair value of GRAIL exceeded its carrying va... | text | 950 | monetaryItemType | text: <entity> 950 </entity> <entity type> monetaryItemType </entity type> <context> In Q4 2023, we concluded, among other events, that our formal announcement to divest GRAIL represented a triggering event that required an additional interim impairment test be performed. As a result of our analysis, no impairment was ... | us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount |
. These decisions, along with a continued and significant decrease in the Company’s stock price and market capitalization, required us to perform an interim impairment test in Q3 2022. Based on our analysis, we concluded GRAIL’s carrying value exceeded its fair value and recorded a goodwill impairment of $ 3,914 millio... | text | 3914 | monetaryItemType | text: <entity> 3914 </entity> <entity type> monetaryItemType </entity type> <context> . These decisions, along with a continued and significant decrease in the Company’s stock price and market capitalization, required us to perform an interim impairment test in Q3 2022. Based on our analysis, we concluded GRAIL’s carry... | us-gaap:GoodwillImpairmentLoss |
for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $ 3 million and $ 6 million, respectively. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of ... | us-gaap:IndefinitelivedIntangibleAssetsAcquired |
for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $ 3 million and $ 6 million, respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $... | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $ 3 million and $ 6 million, respectively. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $ 35 million IPR&D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $... | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We are still finalizing the allocation of the purchase price as it relates to the compl... | text | 42 | monetaryItemType | text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We ... | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We are still finalizing the allocation of the purchase price as it relates to the compl... | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We a... | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We are still finalizing the allocation of the purchase price as it relates to the compl... | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years. We ... | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. | text | 99 | monetaryItemType | text: <entity> 99 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. </context... | us-gaap:InterestExpenseDebt |
Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. | text | 74 | monetaryItemType | text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. </context... | us-gaap:InterestExpenseDebt |
Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $ 99 million, $ 74 million, and $ 21 million in 2024, 2023 and 2022, respectively. </context... | us-gaap:InterestExpenseDebt |
4.650 % Term Notes due 2026 (2026 Term Notes) | text | 4.650 | percentItemType | text: <entity> 4.650 </entity> <entity type> percentItemType </entity type> <context> 4.650 % Term Notes due 2026 (2026 Term Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on S... | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstanding... | us-gaap:DebtInstrumentFaceAmount |
On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on S... | text | 497 | monetaryItemType | text: <entity> 497 </entity> <entity type> monetaryItemType </entity type> <context> On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstanding... | us-gaap:ProceedsFromDebtNetOfIssuanceCosts |
On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on S... | text | 4.650 | percentItemType | text: <entity> 4.650 </entity> <entity type> percentItemType </entity type> <context> On September 9, 2024, we issued $ 500 million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 497 million, which were used to repay a portion of the outstandin... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
5.800 % Term Notes due 2025 (2025 Term Notes) and 5.750 % Term Notes due 2027 (2027 Term Notes) | text | 5.800 | percentItemType | text: <entity> 5.800 </entity> <entity type> percentItemType </entity type> <context> 5.800 % Term Notes due 2025 (2025 Term Notes) and 5.750 % Term Notes due 2027 (2027 Term Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
5.800 % Term Notes due 2025 (2025 Term Notes) and 5.750 % Term Notes due 2027 (2027 Term Notes) | text | 5.750 | percentItemType | text: <entity> 5.750 </entity> <entity type> percentItemType </entity type> <context> 5.800 % Term Notes due 2025 (2025 Term Notes) and 5.750 % Term Notes due 2027 (2027 Term Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which m... | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 mi... | us-gaap:DebtInstrumentFaceAmount |
In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which m... | text | 991 | monetaryItemType | text: <entity> 991 </entity> <entity type> monetaryItemType </entity type> <context> In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 mi... | us-gaap:ProceedsFromDebtNetOfIssuanceCosts |
In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which m... | text | 5.800 | percentItemType | text: <entity> 5.800 </entity> <entity type> percentItemType </entity type> <context> In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 m... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which m... | text | 5.750 | percentItemType | text: <entity> 5.750 </entity> <entity type> percentItemType </entity type> <context> In December 2022, we issued $ 500 million aggregate principal amount of 2025 Term Notes and $ 500 million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 991 m... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
We may redeem for cash all or any portion of the 2025 or 2027 Term Notes, at our option, at any time prior to maturity. Prior to November 12, 2025 for the 2025 Notes and prior to November 13, 2027 for the 2027 Notes, the notes are redeemable at make-whole premium redemption prices as defined in the applicable forms of ... | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> We may redeem for cash all or any portion of the 2025 or 2027 Term Notes, at our option, at any time prior to maturity. Prior to November 12, 2025 for the 2025 Notes and prior to November 13, 2027 for the 2027 Notes, the notes are redee... | us-gaap:DebtInstrumentRedemptionPricePercentage |
0.550 % Term Notes due 2023 (2023 Term Notes) and 2.550 % Term Notes due 2031 (2031 Term Notes) | text | 0.550 | percentItemType | text: <entity> 0.550 </entity> <entity type> percentItemType </entity type> <context> 0.550 % Term Notes due 2023 (2023 Term Notes) and 2.550 % Term Notes due 2031 (2031 Term Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
0.550 % Term Notes due 2023 (2023 Term Notes) and 2.550 % Term Notes due 2031 (2031 Term Notes) | text | 2.550 | percentItemType | text: <entity> 2.550 </entity> <entity type> percentItemType </entity type> <context> 0.550 % Term Notes due 2023 (2023 Term Notes) and 2.550 % Term Notes due 2031 (2031 Term Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes,... | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 milli... | us-gaap:DebtInstrumentFaceAmount |
In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes,... | text | 992 | monetaryItemType | text: <entity> 992 </entity> <entity type> monetaryItemType </entity type> <context> In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 milli... | us-gaap:ProceedsFromDebtNetOfIssuanceCosts |
In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes,... | text | 2.550 | percentItemType | text: <entity> 2.550 </entity> <entity type> percentItemType </entity type> <context> In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 mill... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes,... | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> In March 2021, we issued $ 500 million aggregate principal amount of 2023 Term Notes and $ 500 million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $ 992 millio... | us-gaap:DebtInstrumentRedemptionPricePercentage |
On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $ 750 million on t... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million... | us-gaap:DebtInstrumentFaceAmount |
On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $ 750 million on t... | text | 6.7 | percentItemType | text: <entity> 6.7 </entity> <entity type> percentItemType </entity type> <context> On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million ... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $ 750 million on t... | text | 761 | monetaryItemType | text: <entity> 761 </entity> <entity type> monetaryItemType </entity type> <context> On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million... | us-gaap:RepaymentsOfLongTermDebt |
On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $ 750 million on t... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> On June 17, 2024, we entered into a 364 -day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $ 750 million (... | us-gaap:GainsLossesOnExtinguishmentOfDebt |
0 % Convertible Senior Notes due 2023 (2023 Convertible Notes) | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> 0 % Convertible Senior Notes due 2023 (2023 Convertible Notes) </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In August 2018, we issued $ 750 million aggregate principal amount of 2023 Convertible Notes. The notes were convertible into cash, shares of common stock or a combination of cash and shares of common stock, at our election, based on conversion rates as defined in the indenture. The 2023 Convertible Notes matured on Au... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> In August 2018, we issued $ 750 million aggregate principal amount of 2023 Convertible Notes. The notes were convertible into cash, shares of common stock or a combination of cash and shares of common stock, at our election, based on c... | us-gaap:DebtInstrumentFaceAmount |
The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that do... | text | 3.7 | percentItemType | text: <entity> 3.7 </entity> <entity type> percentItemType </entity type> <context> The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability c... | us-gaap:DebtInstrumentInterestRateEffectivePercentage |
The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that do... | text | 624 | monetaryItemType | text: <entity> 624 </entity> <entity type> monetaryItemType </entity type> <context> The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability ... | us-gaap:ConvertibleDebtFairValueDisclosures |
The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that do... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability ... | us-gaap:DebtInstrumentFaceAmount |
The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that do... | text | 93 | monetaryItemType | text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability c... | us-gaap:AdditionalPaidInCapital |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.